An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: Vaccines

HEPLISAV-B

STN: 125428
Proper Name: Hepatitis B Vaccine (Recombinant), Adjuvanted
Tradename: HEPLISAV-B
Manufacturer: Dynavax Technologies Corporation
Indications:

HEPLISAV-B is indicated for prevention of infection caused by all known subtypes of hepatitis B virus.
HEPLISAV-B is approved for use in adults 18 years of age and older.

Product Information

Package Insert - HEPLISAV-B
Demographic Subgroup Information - Hepatitis B Vaccine (Recombinant), Adjuvanted; HEPLISAV-B
Refer to Section 1.1 of the clinical reviewer memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.

Supporting Documents

Top